WHO Immunization Implementation Guide
0.1.0 - CI Build
WHO Immunization Implementation Guide, published by World Health Organization (WHO). This is not an authorized publication; it is the continuous build for version 0.1.0). This version is based on the current content of https://github.com/WorldHealthOrganization/smart-immunizations and changes regularly. See the Directory of published versions
Contents:
This page provides a list of the FHIR artifacts defined as part of this implementation guide.
These define activities that can be performed as part of the guidelines in this implementation guide.
| IMMZ.DT.01.BCG.01 |
Provide BCG immunizations |
| IMMZ.DT.01.BCG.CR |
Provide BCG immunizations reminder |
| IMMZ.DT.02.HepatitisB.01 |
Provide Hepatitis B immunizations – using the “Hepatitis B vaccine immunization – Birth dose” schedule (Birth dose) |
| IMMZ.DT.02.HepatitisB.CR |
Provide HepB immunizations reminder |
| IMMZ.DT.03.Polio.01 |
Provide Polio (IPV) vaccination |
| IMMZ.DT.03.Polio.01 |
Provide Polio (bOPV) vaccination |
| IMMZ.DT.03.Polio.bOPV.CR |
Provide IPV immunizations reminder |
| IMMZ.DT.03.Polio.bOPV.CR |
Provide bOPV immunizations reminder |
| IMMZ.DT.04.DTP.01 |
Provide DTP immunization 1st dose – using the “DTP vaccine immunization – NO PREVIOUS” schedule (3 dose scheme) if the patient is the older 6 weeks of age |
| IMMZ.DT.05.Hib.01 |
Provide Hib immunizations – using the “Hib Vaccine immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.06.Pneumococcal.01 |
Provide Pneumococcal immunizations |
| IMMZ.DT.07.Rotavirus.01 |
Provide Rotavirus immunizations – using the “Rotavirus vaccine immunization – NO PREVIOUS” schedule (2-3 scheme depends on product) |
| IMMZ.DT.08.Measles.01 |
Provide measles immunization |
| IMMZ.DT.09.Rubella.01 |
Provide Rubella immunizations – using the “Rubella Vaccine immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.10.HPV.01 |
Provide HPV immunizations - using the “HPV vaccine immunization - NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.11.JE.01 |
Provide Japanese Encephalitis immunizations – using the “Japanese Encephalitis vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.12.YellowFever.01 |
Provide Yellow Fever immunizations – using the “Yellow Fever vaccine immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.13.TBE.01 |
Provide Tick-Borne Encephalitis immunizations – using the “FSME-Immun vaccine immunization – NO PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.14.Typhoid.01 |
Provide Typhoid immunizations – using the “TCV vaccine immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.15.Cholera.01 |
Provide Cholera immunizations – using the “WC vaccines (Shanchol, Euvchol, and mORCVAX) immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.15.Cholera.02 |
Provide Cholera immunizations – using the “WC vaccines (Shanchol, Euvchol, and mORCVAX) immunization –1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.15.Cholera.03 |
Provide Cholera revaccination – using the “WC vaccines (Shanchol, Euvchol, and mORCVAX) immunization – Revaccination every 3 years” schedule (2 dose scheme) |
| IMMZ.DT.15.Cholera.04 |
Provide Cholera immunizations – using the “WC-rBS vaccine (Dukoral) immunization – NO PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.15.Cholera.05 |
Provide Cholera immunizations – using the “WC-rBS vaccine (Dukoral) immunization – 1 PREVIOUS” schedule (3 dose scheme), doses to be given in an interval of |
| IMMZ.DT.15.Cholera.06 |
Provide Cholera immunizations – using the “WC-rBS vaccine (Dukoral) immunization – 2 PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.15.Cholera.07 |
Provide Cholera revaccination – using the “WC-rBS vaccine (Dukoral) immunization – Revaccination every 6 months” schedule (1 dose scheme) |
| IMMZ.DT.15.Cholera.08 |
Provide Cholera revaccination – using the “WC-rBS vaccine (Dukoral) immunization – Revaccination” schedule (3 dose scheme) |
| IMMZ.DT.15.Cholera.09 |
Provide Cholera immunizations – using the “WC-rBS vaccine (Dukoral) immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.15.Cholera.10 |
Provide Cholera immunizations – using the “WC-rBS vaccine (Dukoral) immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.15.Cholera.11 |
Provide Cholera revaccination – using the “WC-rBS vaccine (Dukoral) immunization – Revaccination every 2 years” schedule (1 dose scheme) |
| IMMZ.DT.15.Cholera.12 |
Provide Cholera revaccination – using the “WC-rBS vaccine (Dukoral) immunization – Revaccination” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.01 |
Provide Meningococcal immunizations – using the “MenA conjugate vaccine (5µg) immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.02 |
Provide Meningococcal immunizations – using the “MenA conjugate vaccine (5µg) immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.03 |
Provide Meningococcal immunizations – using the “MenA conjugate vaccine (5µg) immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.16.Meningococcal.04 |
Provide Meningococcal immunizations – using the “MenA conjugate vaccine (5µg) immunization – Single non-recurring BOOSTER” schedule (1 dose booster) |
| IMMZ.DT.16.Meningococcal.05 |
Provide Meningococcal immunizations – using the “monovalent MenC conjugate vaccine immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.16.Meningococcal.06 |
Provide Meningococcal immunizations – using the “monovalent MenC conjugate vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.07 |
Provide Meningococcal immunizations – using the “monovalent MenC conjugate vaccine immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.08 |
Provide Meningococcal immunizations – using the “monovalent MenC conjugate vaccine immunization – Single non-recurring BOOSTER” schedule (1 dose booster) |
| IMMZ.DT.16.Meningococcal.09 |
Provide Meningococcal immunizations – using the “monovalent MenC conjugate immunization – Single non-recurring BOOSTER” schedule (1 dose booster) |
| IMMZ.DT.16.Meningococcal.10 |
Provide Meningococcal immunizations – using the “Quadrivalent conjugate vaccines (A,C,W135,Y-D and A,C,W135,Y-CRM) immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.16.Meningococcal.11 |
Provide Meningococcal immunizations – using the “Quadrivalent conjugate vaccines (A,C,W135,Y-D) immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.12 |
Provide Meningococcal immunizations – using the “Quadrivalent conjugate vaccines (A,C,W135,Y-D) immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.13 |
Provide Meningococcal immunizations – using the “Quadrivalent conjugate vaccines (A,C,W135,Y-D) immunization – Single non-recurring BOOSTER” schedule (1 dose booster) |
| IMMZ.DT.17.HepatitisA.01 |
Provide Hepatitis A immunization – using the “Hepatitis A vaccine immunization – NO PREVIOUS” Live attenuated HAV vaccine schedule (1 dose scheme) |
| IMMZ.DT.17.HepatitisA.02 |
Provide Hepatitis A immunization – using the “Hepatitis A vaccine immunization – NO PREVIOUS” Inactivated HAV vaccine schedule (2 dose scheme) |
| IMMZ.DT.17.HepatitisA.03 |
Provide Hepatitis A immunization – using the “Hepatitis A vaccine immunization – 1 PREVIOUS” Inactivated HAV vaccine schedule (2 dose scheme) |
| IMMZ.DT.17.HepatitisA.04 |
Provide Hepatitis A immunization – using the “Hepatitis A vaccine immunization – 1 PREVIOUS” Inactivated HAV vaccine schedule (2 dose scheme) |
| IMMZ.DT.18.Rabies.01 |
Provide Rabies immunizations – using the “PrEP vaccination strategy – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.18.Rabies.02 |
Provide Rabies immunizations – using the “PrEP vaccination strategy – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.18.Rabies.03 |
Provide Rabies immunizations – using the “PrEP vaccination strategy – BOOSTER” schedule (1 dose booster) |
| IMMZ.DT.18.Rabies.04 |
Provide Rabies immunizations – using the “PrEP- IM route immunization – NO PREVIOUS” schedule 1-site IM vaccine administration on days 0 and 7 |
| IMMZ.DT.18.Rabies.05 |
Provide Rabies immunizations – using the “PrEP- IM or ID route immunization – VACCINATED” schedule 1-site ID or a 1-site IM PrEP booster vaccination |
| IMMZ.DT.19.Dengue.01 |
Provide Dengue immunizations – using the “Dengue vaccine immunization – NO PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.19.Dengue.02 |
Provide Dengue immunizations – using the “Dengue vaccine immunization – 1 PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.19.Dengue.03 |
Provide Dengue immunizations – using the “Dengue vaccine immunization – 2 PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.20.Mumps.01 |
Provide MUMPS immunizations - using the “MUMPS vaccine immunization - NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.20.Mumps.02 |
Provide MUMPS immunizations - using the “MUMPS vaccine immunization - 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.21.SeasonalInfluenza.01 |
Provide Seasonal influenza immunizations – using the “Seasonal influenza vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.21.SeasonalInfluenza.02 |
Provide Seasonal influenza immunizations – using the “Seasonal influenza vaccine immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.21.SeasonalInfluenza.03 |
Provide Seasonal influenza revaccination – using the “Seasonal influenza vaccine immunization – Annual dose” schedule (1 dose scheme) |
| IMMZ.DT.22.Varicella.01 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.22.Varicella.02 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.22.Varicella.03 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.22.Varicella.04 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.22.Varicella.05 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.22.Varicella.06 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – 1 PREVIOUS” schedule (2 dose scheme) |
The Beta Group
| IMMZ.DT.01.BCG |
If child or person has not been vaccinated, give BCG vaccine as soon as possible after birth |
| IMMZ.DT.02.HepatitisB |
If child or person has not been vaccinated, give Hepatitis B vaccine as soon as possible after birth |
| IMMZ.DT.03.Polio |
If child or person has not been vaccinated, give Polio vaccine |
| IMMZ.DT.04.DTP |
If child or person has not been given DTP, start scheme |
| IMMZ.DT.05.Hib |
if child or person has not been vaccinated, give Hib vaccine between 6 weeks and 59 months |
| IMMZ.DT.06.Pneumococcal |
If child or person has not been vaccinated, give Pneumococcal vaccine minimum age 6 weeks old |
| IMMZ.DT.07.Rotavirus |
If child or person has not been vaccinated, give Rotavirus vaccine according to the defined schedule |
| IMMZ.DT.08.Measles |
If the child or patient has not been given MCV1 (at 9 months) and MCV2 (between 15-18 months) vaccination |
| IMMZ.DT.09.Rubella |
If child or patient has not received the Rubella vaccination and is greater than or equal to 9 months |
| IMMZ.DT.10.HPV |
If child or person has not been vaccinated, give HPV vaccine according to the defined schedule |
| IMMZ.DT.11.JapaneseEncephalitis |
If child or person has not been vaccinated, give Japanese Encephalitis vaccine according to the defined schedule |
| IMMZ.DT.12.YellowFever |
If child or person has not been vaccinated, give Yellow Fever vaccine between age 9-12 months |
| IMMZ.DT.13.Tick-BorneEncephalitis |
If child or person has not been vaccinated, give Tick-Borne Encephalitis vaccine according to the defined schedule |
| IMMZ.DT.14.Typhoid |
If child or person has not been vaccinated, give the Typhoid vaccine between age 6 months - 45 years old |
| IMMZ.DT.15.Cholera |
If child or person has not been vaccinated, give the Cholera vaccine to child greater than or equal to 1 year old and adults |
| IMMZ.DT.16.Meningococcal |
If child or person has not been vaccinated, give Meningococcal vaccine according to the defined schedule |
| IMMZ.DT.17.HepatitisA |
If child or person has not been vaccinated, give Hepatitis A vaccine at 1 year of age |
| IMMZ.DT.18.Rabies |
If patient has not been vaccinated, give Rabies vaccine |
| IMMZ.DT.19.Dengue |
If child or person has not been vaccinated, give Dengue vaccine between 9 and 45 years of age |
| IMMZ.DT.20.Mumps |
If child or person has not been vaccinated against Mumps, give Mumps vaccine |
| IMMZ.DT.21.SeasonalInfluenza |
If child or person has not been vaccinated, give Seasonal Influenza vaccine at 6 months of age, and then once a year. |
| IMMZ.DT.22.Varicella |
If child or person has not been vaccinated against Varicella |
These define activities that can be performed as part of content in this implementation guide.
| IMMZ.DT.01.BCG.01 |
Provide BCG immunizations |
| IMMZ.DT.01.BCG.CR |
Provide BCG immunizations reminder |
| IMMZ.DT.02.HepatitisB.01 |
Provide Hepatitis B immunizations – using the “Hepatitis B vaccine immunization – Birth dose” schedule (Birth dose) |
| IMMZ.DT.02.HepatitisB.CR |
Provide HepB immunizations reminder |
| IMMZ.DT.03.Polio.01 |
Provide Polio (IPV) vaccination |
| IMMZ.DT.03.Polio.01 |
Provide Polio (bOPV) vaccination |
| IMMZ.DT.03.Polio.bOPV.CR |
Provide IPV immunizations reminder |
| IMMZ.DT.03.Polio.bOPV.CR |
Provide bOPV immunizations reminder |
| IMMZ.DT.04.DTP.01 |
Provide DTP immunization 1st dose – using the “DTP vaccine immunization – NO PREVIOUS” schedule (3 dose scheme) if the patient is the older 6 weeks of age |
| IMMZ.DT.05.Hib.01 |
Provide Hib immunizations – using the “Hib Vaccine immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.06.Pneumococcal.01 |
Provide Pneumococcal immunizations |
| IMMZ.DT.07.Rotavirus.01 |
Provide Rotavirus immunizations – using the “Rotavirus vaccine immunization – NO PREVIOUS” schedule (2-3 scheme depends on product) |
| IMMZ.DT.08.Measles.01 |
Provide measles immunization |
| IMMZ.DT.09.Rubella.01 |
Provide Rubella immunizations – using the “Rubella Vaccine immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.10.HPV.01 |
Provide HPV immunizations - using the “HPV vaccine immunization - NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.11.JE.01 |
Provide Japanese Encephalitis immunizations – using the “Japanese Encephalitis vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.12.YellowFever.01 |
Provide Yellow Fever immunizations – using the “Yellow Fever vaccine immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.13.TBE.01 |
Provide Tick-Borne Encephalitis immunizations – using the “FSME-Immun vaccine immunization – NO PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.14.Typhoid.01 |
Provide Typhoid immunizations – using the “TCV vaccine immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.15.Cholera.01 |
Provide Cholera immunizations – using the “WC vaccines (Shanchol, Euvchol, and mORCVAX) immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.15.Cholera.02 |
Provide Cholera immunizations – using the “WC vaccines (Shanchol, Euvchol, and mORCVAX) immunization –1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.15.Cholera.03 |
Provide Cholera revaccination – using the “WC vaccines (Shanchol, Euvchol, and mORCVAX) immunization – Revaccination every 3 years” schedule (2 dose scheme) |
| IMMZ.DT.15.Cholera.04 |
Provide Cholera immunizations – using the “WC-rBS vaccine (Dukoral) immunization – NO PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.15.Cholera.05 |
Provide Cholera immunizations – using the “WC-rBS vaccine (Dukoral) immunization – 1 PREVIOUS” schedule (3 dose scheme), doses to be given in an interval of |
| IMMZ.DT.15.Cholera.06 |
Provide Cholera immunizations – using the “WC-rBS vaccine (Dukoral) immunization – 2 PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.15.Cholera.07 |
Provide Cholera revaccination – using the “WC-rBS vaccine (Dukoral) immunization – Revaccination every 6 months” schedule (1 dose scheme) |
| IMMZ.DT.15.Cholera.08 |
Provide Cholera revaccination – using the “WC-rBS vaccine (Dukoral) immunization – Revaccination” schedule (3 dose scheme) |
| IMMZ.DT.15.Cholera.09 |
Provide Cholera immunizations – using the “WC-rBS vaccine (Dukoral) immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.15.Cholera.10 |
Provide Cholera immunizations – using the “WC-rBS vaccine (Dukoral) immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.15.Cholera.11 |
Provide Cholera revaccination – using the “WC-rBS vaccine (Dukoral) immunization – Revaccination every 2 years” schedule (1 dose scheme) |
| IMMZ.DT.15.Cholera.12 |
Provide Cholera revaccination – using the “WC-rBS vaccine (Dukoral) immunization – Revaccination” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.01 |
Provide Meningococcal immunizations – using the “MenA conjugate vaccine (5µg) immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.02 |
Provide Meningococcal immunizations – using the “MenA conjugate vaccine (5µg) immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.03 |
Provide Meningococcal immunizations – using the “MenA conjugate vaccine (5µg) immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.16.Meningococcal.04 |
Provide Meningococcal immunizations – using the “MenA conjugate vaccine (5µg) immunization – Single non-recurring BOOSTER” schedule (1 dose booster) |
| IMMZ.DT.16.Meningococcal.05 |
Provide Meningococcal immunizations – using the “monovalent MenC conjugate vaccine immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.16.Meningococcal.06 |
Provide Meningococcal immunizations – using the “monovalent MenC conjugate vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.07 |
Provide Meningococcal immunizations – using the “monovalent MenC conjugate vaccine immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.08 |
Provide Meningococcal immunizations – using the “monovalent MenC conjugate vaccine immunization – Single non-recurring BOOSTER” schedule (1 dose booster) |
| IMMZ.DT.16.Meningococcal.09 |
Provide Meningococcal immunizations – using the “monovalent MenC conjugate immunization – Single non-recurring BOOSTER” schedule (1 dose booster) |
| IMMZ.DT.16.Meningococcal.10 |
Provide Meningococcal immunizations – using the “Quadrivalent conjugate vaccines (A,C,W135,Y-D and A,C,W135,Y-CRM) immunization – NO PREVIOUS” schedule (1 dose scheme) |
| IMMZ.DT.16.Meningococcal.11 |
Provide Meningococcal immunizations – using the “Quadrivalent conjugate vaccines (A,C,W135,Y-D) immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.12 |
Provide Meningococcal immunizations – using the “Quadrivalent conjugate vaccines (A,C,W135,Y-D) immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.16.Meningococcal.13 |
Provide Meningococcal immunizations – using the “Quadrivalent conjugate vaccines (A,C,W135,Y-D) immunization – Single non-recurring BOOSTER” schedule (1 dose booster) |
| IMMZ.DT.17.HepatitisA.01 |
Provide Hepatitis A immunization – using the “Hepatitis A vaccine immunization – NO PREVIOUS” Live attenuated HAV vaccine schedule (1 dose scheme) |
| IMMZ.DT.17.HepatitisA.02 |
Provide Hepatitis A immunization – using the “Hepatitis A vaccine immunization – NO PREVIOUS” Inactivated HAV vaccine schedule (2 dose scheme) |
| IMMZ.DT.17.HepatitisA.03 |
Provide Hepatitis A immunization – using the “Hepatitis A vaccine immunization – 1 PREVIOUS” Inactivated HAV vaccine schedule (2 dose scheme) |
| IMMZ.DT.17.HepatitisA.04 |
Provide Hepatitis A immunization – using the “Hepatitis A vaccine immunization – 1 PREVIOUS” Inactivated HAV vaccine schedule (2 dose scheme) |
| IMMZ.DT.18.Rabies.01 |
Provide Rabies immunizations – using the “PrEP vaccination strategy – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.18.Rabies.02 |
Provide Rabies immunizations – using the “PrEP vaccination strategy – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.18.Rabies.03 |
Provide Rabies immunizations – using the “PrEP vaccination strategy – BOOSTER” schedule (1 dose booster) |
| IMMZ.DT.18.Rabies.04 |
Provide Rabies immunizations – using the “PrEP- IM route immunization – NO PREVIOUS” schedule 1-site IM vaccine administration on days 0 and 7 |
| IMMZ.DT.18.Rabies.05 |
Provide Rabies immunizations – using the “PrEP- IM or ID route immunization – VACCINATED” schedule 1-site ID or a 1-site IM PrEP booster vaccination |
| IMMZ.DT.19.Dengue.01 |
Provide Dengue immunizations – using the “Dengue vaccine immunization – NO PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.19.Dengue.02 |
Provide Dengue immunizations – using the “Dengue vaccine immunization – 1 PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.19.Dengue.03 |
Provide Dengue immunizations – using the “Dengue vaccine immunization – 2 PREVIOUS” schedule (3 dose scheme) |
| IMMZ.DT.20.Mumps.01 |
Provide MUMPS immunizations - using the “MUMPS vaccine immunization - NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.20.Mumps.02 |
Provide MUMPS immunizations - using the “MUMPS vaccine immunization - 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.21.SeasonalInfluenza.01 |
Provide Seasonal influenza immunizations – using the “Seasonal influenza vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.21.SeasonalInfluenza.02 |
Provide Seasonal influenza immunizations – using the “Seasonal influenza vaccine immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.21.SeasonalInfluenza.03 |
Provide Seasonal influenza revaccination – using the “Seasonal influenza vaccine immunization – Annual dose” schedule (1 dose scheme) |
| IMMZ.DT.22.Varicella.01 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.22.Varicella.02 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.22.Varicella.03 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.22.Varicella.04 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – 1 PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.22.Varicella.05 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – NO PREVIOUS” schedule (2 dose scheme) |
| IMMZ.DT.22.Varicella.06 |
Provide Varicella immunizations – using the “Varicella vaccine immunization – 1 PREVIOUS” schedule (2 dose scheme) |
These define measures as part of content in this implementation guide.
| IMMZ.IND.01 Immunization coverage for BCG (Estimated Denominator) |
Compares the doses of BCG vaccine administered with the estimated number of live births as a percentage. |
| IMMZ.IND.02 Immunization coverage for DTP containing vaccines (Estimated Denominator) |
Compares the administered doses of a DTP containing vaccine with the estimated number of surviving infants as a percentage. |
| IMMZ.IND.03 Immunization coverage for HepB containing vaccines birth dose (estimated denominator) |
Compares the administered dosesof Hepatitus B containing vaccine given at birth (dose sequence 0) with the number of live births. |
| IMMZ.IND.04 Immunization coverage for HepB containing vaccines (Estimated Denominator) |
Compares the administered doses of Hepatitis B containing vaccine with the estimated number of live births (if dose sequence is 1 or 2) or number of surviving infants (for dose 3 - if given) |
| IMMZ.IND.05 Immunization coverage for inactivated polio containing vaccine (Estimated Denominator) |
Compares the administered doses of inactivated polio containing vaccines (IPV) with the estimated number of surviving infants expressed as a percentage. |
| IMMZ.IND.06 Immunization coverage for oral polio containing vaccine birth doses (Estimated Denominator) |
Compares the administered doses of oral polio containing vaccines (OPV) given at birth (dose sequence 0) with the number of live births. This indicator should only be used in contexts where an OPV birth dose is administered. |
| IMMZ.IND.07 Immunization coverage for non-birth doses of oral polio containing vaccine (Estimated Denominator) |
Compares the administered doses of oral polio containing vaccines (OPV) which are non-birth doses (dose sequence > 0) with the estimated number of surviving infants expressed as a percentage. |
| IMMZ.IND.08 Immunization coverage for Measles containing vaccine (Estimated Denominator) |
Compares the administered doses of measles containing vaccines (MCV) with the estimated number of surviving infants (if dose 1) or a country supplied denominator (if dose 2) expressed as a percentage. |
| IMMZ.IND.09 Immunization coverage for HPV (Estimated Denominator) |
Compares the administered doses of HPV vaccines with the country specified denominator for HPV coverage expressed as a percentage. |
| IMMZ.IND.10 Immunization coverage for Meningococcal containing vaccine (Estimated Denominator) |
Compares the administered doses of meningococcal containing vaccine with the number of estimated surviving infants expressed as a percentage. |
| IMMZ.IND.11 Immunization coverage for Pneumococcal containing vaccine (Estimated Denominator) |
Compares the administered doses of pneumococcal containing vaccine with the number of surviving infants (with the exception of final dose which is country supplied denominator definition) expressed as a percentage |
| IMMZ.IND.12 Immunization coverage for Hemophilus containing vaccine (Estimated Denominator) |
Compares the administered doses of haemophilus containing vaccine with the estimated number of surviving infants expressed as a percentage |
| IMMZ.IND.13 Immunization coverage for Rotavirus containing vaccines (Estimated Denominator) |
Compares the administered doses of rotavirus containing vaccine with the number of surviving infants expressed as a percentage |
| IMMZ.IND.14 Immunization coverage for Rubella containing vaccines (Estimated Denominator) |
Compares the administered doses of rubella containing vaccine (RCV) with a country specified denominator expressed as a percentage. |
| IMMZ.IND.15 Immunization coverage for Varicella vaccinations (Estimated Denominator) |
Compares the administered doses of varicella containing vaccine with a country specified denominator expressed as a percentage. |
| IMMZ.IND.16 Immunization coverage for Diphtheria containing vaccine boosters (Estimated Denominator) |
Compares the administered booster doses (4, 5, 6) for diphtheria containing vaccine with a country specified denominator expressed as a percentage. |
| IMMZ.IND.17 Immunization coverage for Pertussis containing vaccine boosters (Estimated Denominator) |
Compares the administered booster dose of pertussis containing vaccine (dose 4) with a country specified denominator expressed as a percentage. |
| IMMZ.IND.18 Immunization coverage for Tetanus containing vaccine boosters (Estimated Denominator) |
Compares the administered booster dose of tetanus containing vaccines (doses 4, 5, 6) with a country specified denominator expressed as a percentage |
| IMMZ.IND.19 Immunization coverage for Yellow Fever vaccine (Estimated Denominator) |
Compares the administered dose of yellow fever vaccine with the number of surviving infants. |
| IMMZ.IND.20 Immunization coverage for Japanese encephalitis vaccines (Estimated Denominator) |
Compares the administered doses of Japanese encephalitis vaccines with a country specified target population expressed as a percentage. |
| IMMZ.IND.21 Immunization coverage for Typhoid vaccines (Estimated Denominator) |
Compares the administered doses of Typhoid vaccines with a country defined target population expressed as a percentage. |
| IMMZ.IND.22 Immunization coverage for seasonal influenza (Estimated Denominator) |
Compares the administered doses of seasonal influenza vaccines with country defined target population (at risk) expressed as a percentage |
| IMMZ.IND.23 Dropout Rate of DTP1 to DTP3 (Target / Reported Cohort) |
Indicates the aggregate dropout rate of DTP containing vaccines protocol. The indicator compares the number of administrations of first dose of DTP containing vaccines (DTP1) minus the number of administrations of the final dose (DTP3) protocol divided by the number of administrations of first dose (DTP1 - DTP3 / DTP1) |
| IMMZ.IND.24 Dropout Rate of BCG to MCV1 (Target / Reported Cohort) |
Indicates the aggregate dropout rate of children which have begun vaccination (at birth, BCG if given) with aggregate administration of measles containing vaccines. The indicator compares the number of administration of BCG minus the number of administration of MCV1 divided by the number of BCG vaccinations (BCG - MCV1 / BCG) |
| IMMZ.IND.25 Dropout Rate of MCV1 to MCV2 (Target / Reported Cohort) |
Indicates the aggregate dropout rate of children which began vaccination of measles containing vaccines (MCV1) with the aggregate administration of the second dose (MCV2). The indicator compares the number of administrations of MCV dose 1 minus the number of administration of MCV2 divided by the number of MCV1 vaccinations (MCV1 - MCV2 / MCV1) |
| IMMZ.IND.30 Adverse Event Following Immunization (AEFI) case rate. |
Clinics should report adverse events (reported and confirmed) to the central authority. This should be tracked as an aggregate tally (which should indicate the severity, and optionally the manifestation such as rash, vomiting, etc.), with severe cases being reported using case reporting forms, and should include an analysis of whether the AEFI was a direct result (confirmed) of vaccination or not (suspected). Serious cases are those which involved hospitalization, disability, or death. Investigation of AEFI events can lead to withdrawal of the vaccine from the market, or inform further guidance on administration of a particular antigen/product. |
| IMMZ.IND.32 Immunization coverage for BCG (Computed Denominator) |
Compares the administered doses of BCG vaccine with the actual number of registered, surviving infants expressed as a percentage. |
| IMMZ.IND.33 Immunization coverage for DTP containing vaccines (Computed Denominator) |
Compares the administered doses of a DTP containing vaccine with the registered number of surviving infants expressed as a percentage. |
| IMMZ.IND.34 Immunization coverage for HepB containing vaccines (Computed Denominator) |
Compares the administered dose of HebB containing vaccines with the number of registered, surviving infants expressed as a percentage. |
| IMMZ.IND.35 Immunization coverage for inactivated polio containing vaccine (Computed Denominator) |
Compares the administered doses of inactive polio containing vaccines with the number of registered surviving infants expressed as a percentage. |
| IMMZ.IND.36 Immunization coverage for Measles containing vaccine (Computed Denominator) |
Compares the administered doses of measles containing vaccines with the number of registered surviving infants. |
| IMMZ.IND.37 Immunization coverage for HPV (Computed Denominator) |
Compares the administered doses of HPV vaccines with the number of patients which have an immunization recommendation for HPV vaccine |
| IMMZ.IND.38 Immunization coverage for Meningococcal containing vaccine (Computed Denominator) |
Compares the administered doses of a meningococcal containing vaccine with the number of registered surviving infants. |
| IMMZ.IND.39 Immunization coverage for Pneumococcal containing vaccine (Computed Denominator) |
Compares the administered doses of a pneumococcal containing vaccine with the number of registered surviving infants expressed as a percentage. |
| IMMZ.IND.40 Immunization coverage for Haemophilus containing vaccine (Computed Denominator) |
Compares the administered doses of haemophilus containing vaccine with the registered number of surviving infants, expressed as a percentage . |
| IMMZ.IND.41 Immunization coverage for Rotavirus containing vaccines (Computed Denominator) |
Compares the administered doses of rotavirus containing vaccine with the number of registered children (under 2) expressed as a percentage |
| IMMZ.IND.42 Immunization coverage for Rubella containing vaccines (Computed Denominator) |
Compares the administered doses of rubella containing vaccine (RCV) with the number of immunization recommendations for rubella containing vaccines expressed as a percentage. |
| IMMZ.IND.43 Immunization coverage for Varicella vaccinations (Computed Denominator) |
Compares the administered doses of varicella containing vaccine with the number of immunization recommendations for varicella vaccines expressed as a percentage. |
| IMMZ.IND.44 Immunization coverage for Diphtheria containing vaccine boosters (Computed Denominator) |
Compares the administered booster doses (4, 5, 6) for diphtheria containing vaccine with the number of immunization recommendations for boosters of diphtheria containing vaccines expressed as a percentage. |
| IMMZ.IND.45 Immunization coverage for Pertussis containing vaccine boosters (Computed Denominator) |
Compares the administered booster dose of pertussis containing vaccine (dose 4) with the number of immunization recommendations for boosters of pertussis containing vaccines expressed as a percentage. |
| IMMZ.IND.46 Immunization coverage for Tetanus containing vaccine boosters (Computed Denominator) |
Compares the administered booster dose of tetanus containing vaccines (doses 4, 5, 6) with the number of immunization recommendations for boosters of tetanus containing vaccines expressed as a percentage. |
| IMMZ.IND.47 Immunization coverage for Yellow Fever vaccine (Computed Denominator) |
Compares the administered dose of yellow fever vaccine with the number of registered surviving infants expressed as a percentage. |
| IMMZ.IND.48 Immunization coverage for Japanese encephalitis vaccines (Computed Denominator) |
Compares the administered doses of Japanese encephalitis vaccines with the number of immunization recommendations for Japanese encephalitis expressed as a percentage. |
| IMMZ.IND.49 Immunization coverage for Typhoid vaccines (Computed Denominator) |
Compares the administered doses of Typhoid vaccines with the number of immunization recommendations for typhoid vaccines expressed as a percentage. |
| IMMZ.IND.50 Dropout Rate of DTP1 to DTP3 (Individuals) |
Indicates the number of individuals which have dropped out of the DTP containing vaccine protocol (i.e. children which have received DTP1 but not DTP3). This indicator works by counting the number of individuals who have received the first dose of DTP (dose 1) containing vaccine but not the last dose of DTP (are past-due for dose 3) with the children who have completed the vaccination protocol. |
| IMMZ.IND.51 Dropout Rate of BCG to MCV1 (Individuals) |
Indicates the number of individuals which received a BCG dose at birth (or early life) yet did not receive the first dose of a measles containing vaccine (MCV). This indicator works by counting the number of individuals who have received a BCG dose, who have not received a MCV1 dose (are past due for MCV1) with the children who have received BCG and MCV1 doses. |
| IMMZ.IND.52 Dropout Rate of MCV1 to MCV2 (Individuals) |
Indicates the number of individuals which have dropped out of the measles containing vaccine protocol. The indicator counts the number of individuals who have received a measles containing vaccine dose 1, yet have not received the final dose of measles containing vaccine (are past due of MCV2) with the individuals who have received MCV1 and MCV2 |
| IMMZ.IND.53 Immunization coverage for HepB containing vaccines birth dose (computed denominator) |
Compares the administered dosesof Hepatitus B containing vaccine given at birth (dose sequence 0) with the actual number of live births. |
| IMMZ.IND.54 Immunization coverage for oral polio containing vaccine birth doses (Estimated Denominator) |
Compares the administered doses of oral polio containing vaccines (OPV) given at birth (dose sequence 0) with the number of live births. This indicator should only be used in contexts where an OPV birth dose is administered. |
| IMMZ.IND.55 Immunization coverage for non-birth doses of oral polio containing vaccine (Estimated Denominator) |
Compares the administered doses of oral polio containing vaccines (OPV) which are non-birth doses (dose sequence > 0) with the estimated number of surviving infants expressed as a percentage. |
These define logic, asset collections and other libraries as part of content in this implementation guide.
These define constraints on FHIR data types for systems conforming to this implementation guide.
| Communication consent |
Indication that client gave consent to be contacted |
| Estimated age |
If DOB is unknown, enter the client’s age. Note displaying the client’s age in years. |
| Highest level of education achieved |
The highest level of school the client has reached. |
| Insurance coverage |
Does the client have insurance coverage? |
| Miscarriage or abortion stage of pregnancy |
If the woman recently had a miscarriage or abortion, when in the pregnancy the abortion took place. |
| Occupation | |
| Payment method | |
| Referred by |
How the client was referred |
| Reminder messages |
Whether client wants to receive text or other messages as follow-up for family planning |
These define sets of codes used by systems conforming to this implementation guide.
| ARV Drugs values |
Codes representing ARV Drugs values |
| Birthweight valueset |
Codes representing Birthweight values |
| CD4 Count Test Result |
Codes representing CD4 Count Test Result values |
| CD4 Percentage Test |
Codes representing CD4 Percentage Test values |
| Encepur Class TBE Vaccine values |
Codes representing Encepur Class TBE Vaccine values |
| EnceVir Class TBE Vaccine values |
Codes representing EnceVir Class TBE Vaccine values |
| FSME-Immun Class TBE Vaccine values |
Codes representing FSME-Immun Class TBE Vaccine values |
| HIV status values |
Codes representing HIV status values |
| IGRA Test Result values |
Codes representing IGRA Test Result values |
| Immunocompromised valueset |
Codes representing Immunocompromised values |
| Inactivated Vero cell-derived Japanese Encephalitis vaccines valueset |
Codes representing Inactivated Vero cell-derived Japanese Encephalitis vaccines values |
| Intussusception valueset |
Codes representing Intussuception values |
| MenA conjugate vaccine values |
Codes representing MenA conjugate vaccine values |
| monovalent MenC conjugate values |
Codes representing monovalent MenC conjugate values |
| Negative Test Results |
Codes representing negative test result values |
| Positive Test Result valuest |
Codes representing Positive Test Result values |
| Preterm valueset |
Codes representing Preterm values |
| Quadrivalent conjugate values |
Codes representing Quadrivalent conjugate values |
| Seronegative valuest |
Codes representing Seronegative values |
| Sickle Cell valuest |
Codes representing Sickle Cell values |
| TBE-Moscow Class TBE Vaccine values |
Codes representing TBE-Moscow Class TBE Vaccine values |
| TCV Class Typhoid Vaccine values |
Codes representing ViPS Class Typhoid Vaccine values |
| TST Test Result values |
Codes representing TST Test Result values |
| Ty21a Class Typhoid Vaccine values |
Codes representing Ty21a Class Typhoid Vaccine values |
| ViPS Class Typhoid Vaccine values |
Codes representing ViPS Class Typhoid Vaccine values |
| VNA Level Rabies valueset |
Codes representing Virus Neutralizing Antibody Levels values |
| WC Class Cholera Vaccine values |
Codes representing WC Class Cholera Vaccine values |
| WC-rBS Class Cholera Vaccine values |
Codes representing WC-rBS Class Cholera Vaccine values |
These define new code systems used by systems conforming to this implementation guide.
| WHO Extended Codes CodeSystem codes |
Set of codes identified as being needed but not found in existing Code Systems |